CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Other events
- 8-K Event Agreement ended · Executive or director change · Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 120,000 shares at $0.41 ($48,600)
- 4 Open-market buy Chief Executive Officer bought 98,000 shares at $0.43 ($41,924)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 10,000 shares
- 4 Open-market buy Director bought 25,000 shares
- 4 Open-market buy Director bought 100,000 shares
- 8-K Event Other events
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Delisting notice
Page 53 of 76 · 1,519 filings